Madrigal Pharmaceuticals ...

NASDAQ: MDGL · Real-Time Price · USD
369.75
-1.62 (-0.44%)
At close: Aug 15, 2025, 3:59 PM
344.50
-6.83%
After-hours: Aug 15, 2025, 07:58 PM EDT

Madrigal Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-42.28M -73.24M -59.42M -106.96M -151.97M -147.54M -112.19M -98.74M -85.8M -76.9M -85.91M -81.2M -70.73M -57.52M -64.55M -63.1M -61.65M -52.55M
Depreciation & Amortization
377K 435K 363K 298K 267K 168K 142K 135K 126K 124K 129K 121K 110K 107K 106K 97K 89K 113K
Stock-Based Compensation
25.16M 20.93M 17.68M 17.9M 24.4M 19.9M 14.85M 12.66M 10.97M 11.25M 8.08M 8.12M 7.94M 7.48M 6.36M 6.24M 8.18M 6.1M
Other Working Capital
-1.53M -7.13M -12.57M 10M 12.53M -9.97M 5.01M 1.34M -6.57M 11.7M 13.6M 6.3M 16.62M -1.38M -926K 1.85M 9.83M -471K
Other Non-Cash Items
26.53M -37.02M 540K 22K 39.16M 33.26M 4.39M 674K 554K 433K 306K 313K 178K 6.29M 30.65M -2.92M 11.69M 2.94M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -3.64M n/a n/a n/a n/a n/a n/a n/a -30.65M n/a n/a n/a
Change in Working Capital
-31.68M -37.45M -63.65M 21.76M -8.12M -22.34M 16.51M 351K -1.16M -18.98M 18.87M 13.57M 5.14M 21K 10.04M 11.21M 6.5M 2.91M
Operating Cash Flow
-47.05M -88.89M -104.49M -66.98M -134.94M -149.16M -79.93M -84.92M -75.31M -84.07M -58.52M -59.07M -57.36M -49.91M -48.05M -45.56M -46.88M -43.43M
Capital Expenditures
n/a n/a -195K -779K -5.13M -357K -1.04M -339K -69K -35K -29K -33K -103K -52K -113K -50K -2K -44K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a 361.09K -50.54K 3.66K -2.17M -3K -65.17K -19.34K 106K 787K n/a n/a 485K
Purchase of Investments
-225.53M -130.81M -350.19M -416.03M -280.79M -84.2M -474.89M -68.85M -91.87M -198.82M -12.79M -14.2M -78.93M -37.57M -54.75M -115.3M -130.35M -93.72M
Sales Maturities Of Investments
273.39M 297.54M 302.43M 214.42M 163.82M 182.61M 113.8M 119.39M 88.21M 11.99M 79.2M 79.37M 98.27M 93.55M 70.5M 155.44M 103.03M 60.3M
Other Investing Acitivies
n/a -2.85M n/a n/a -121.97M 98.41M -361.09K 50.54K -3.66K 2.17M 3K 65.17K 19.34K -106K -787K 40.14K -27.32K -485K
Investing Cash Flow
47.86M 163.88M -47.95M -202.39M -122.1M 98.05M -362.12M 50.2M -3.73M -186.86M 66.39M 65.14M 19.24M 55.93M 15.64M 40.09M -27.32M -33.46M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a 15M 15M 35M n/a n/a 50M n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a 8.64M n/a 7.46M 48.17M 262.14M 244.21M 1.85M 6.18M 17.69M 8.96M n/a -886K n/a 545K 7K n/a 478K
Financial Cash Flow
1.74M 8.64M 19.77M 7.46M 134.12M 573.71M 479.92M 19.58M 42.93M 52.69M 264.34M n/a 49.11M n/a 19.5M 21.1M 63.54M 67.09M
Net Cash Flow
2.55M 83.63M -132.66M -261.91M -122.92M 522.6M 37.86M -15.14M -36.11M -218.24M 272.21M 6.07M 10.99M 6.01M -12.9M 15.63M -10.66M -9.8M
Free Cash Flow
-47.05M -88.89M -104.68M -67.76M -140.08M -149.51M -80.97M -85.26M -75.38M -84.1M -58.54M -59.1M -57.46M -49.97M -48.16M -45.61M -46.88M -43.47M